Anthony M Alvarado1, Kendra M Ward2, Devin S Muntz1, Alexis A Thompson1, Mark Rodeghier3, Bo Fernhall4, Robert I Liem5. 1. Hematology, Oncology, & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. 2. Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. 3. Rodeghier Consultants, Chicago, IL. 4. Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL. 5. Hematology, Oncology, & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: rliem@luriechildrens.org.
Abstract
OBJECTIVE: To examine heart rate recovery (HRR) as an indicator of autonomic nervous system dysfunction after maximal exercise testing in children and young adults with sickle cell anemia (SCA). STUDY DESIGN: Recovery phase heart rate (HR) in the first 5 minutes after maximal exercise testing in 60 subjects with SCA and 30 matched controls without SCA was assessed. The difference between peak HR and HR at both 1-minute (ΔHR1min) and 2-minutes recovery was our primary outcome. RESULTS: Compared with controls, subjects with SCA demonstrated significantly smaller mean ΔHR1min (23 beats per minute [bpm], 95% CI 20-26 vs 32 bpm, 95% CI 26-37, P = .006) and the difference between maximal HR and HR at 2 minutes (39 bpm, 95% CI 36-43 vs 48 bpm, 95% CI 42-53, P = .011). Subjects with SCA also showed smaller mean changes in HR from peak HR to 1 minute, from 1 minute to 2 minutes, and from 2 through 5 minutes of recovery by repeated-measures testing. In a multivariable regression model, older age was independently associated with smaller ΔHR1min in subjects with SCA. Cardiopulmonary fitness and hydroxyurea use, however, were not independent predictors of ΔHR1min. CONCLUSIONS: Children with SCA demonstrate impaired HRR after maximal exercise. Reduced postexercise HRR in SCA suggests impaired parasympathetic function, which may become progressively worse with age, in this population.
OBJECTIVE: To examine heart rate recovery (HRR) as an indicator of autonomic nervous system dysfunction after maximal exercise testing in children and young adults with sickle cell anemia (SCA). STUDY DESIGN: Recovery phase heart rate (HR) in the first 5 minutes after maximal exercise testing in 60 subjects with SCA and 30 matched controls without SCA was assessed. The difference between peak HR and HR at both 1-minute (ΔHR1min) and 2-minutes recovery was our primary outcome. RESULTS: Compared with controls, subjects with SCA demonstrated significantly smaller mean ΔHR1min (23 beats per minute [bpm], 95% CI 20-26 vs 32 bpm, 95% CI 26-37, P = .006) and the difference between maximal HR and HR at 2 minutes (39 bpm, 95% CI 36-43 vs 48 bpm, 95% CI 42-53, P = .011). Subjects with SCA also showed smaller mean changes in HR from peak HR to 1 minute, from 1 minute to 2 minutes, and from 2 through 5 minutes of recovery by repeated-measures testing. In a multivariable regression model, older age was independently associated with smaller ΔHR1min in subjects with SCA. Cardiopulmonary fitness and hydroxyurea use, however, were not independent predictors of ΔHR1min. CONCLUSIONS:Children with SCA demonstrate impaired HRR after maximal exercise. Reduced postexercise HRR in SCA suggests impaired parasympathetic function, which may become progressively worse with age, in this population.
Authors: D M Prado; A G Silva; I C Trombetta; M M Ribeiro; I C Guazzelli; L N Matos; M S Santos; C M Nicolau; C E Negrão; S M Villares Journal: Int J Sports Med Date: 2010-11-11 Impact factor: 3.118
Authors: Peter Kokkinos; Jonathan Myers; Michael Doumas; Charles Faselis; Andreas Pittaras; Athanasios Manolis; John Peter Kokkinos; Puneet Narayan; Vasilios Papademetriou; Ross Fletcher Journal: Eur J Prev Cardiol Date: 2011-02-25 Impact factor: 7.804
Authors: Xavier Jouven; Jean-Philippe Empana; Peter J Schwartz; Michel Desnos; Dominique Courbon; Pierre Ducimetière Journal: N Engl J Med Date: 2005-05-12 Impact factor: 91.245
Authors: Mercedes R Carnethon; Barbara Sternfeld; Kiang Liu; David R Jacobs; Pamela J Schreiner; O Dale Williams; Cora E Lewis; Stephen Sidney Journal: Med Sci Sports Exerc Date: 2012-02 Impact factor: 5.411
Authors: K Imai; H Sato; M Hori; H Kusuoka; H Ozaki; H Yokoyama; H Takeda; M Inoue; T Kamada Journal: J Am Coll Cardiol Date: 1994-11-15 Impact factor: 24.094
Authors: Charalampos D Kriatselis; Sotirios Nedios; Sebastian Kelle; Sebastian Helbig; Martin Gottwik; Christian von Bary Journal: Cardiol Res Pract Date: 2012-01-24 Impact factor: 1.866
Authors: Kelly A Dougherty; Chiara Bertolaso; Joan I Schall; Kim Smith-Whitley; Virginia A Stallings Journal: J Pediatr Hematol Oncol Date: 2018-07 Impact factor: 1.289
Authors: Pedro Ángel Latorre-Román; Martínez Martínez-Redondo; Jesus Salas-Sánchez; Pedro José Consuegra-González; Elena Sarabia-Cachadiña; Jerónimo Aragón-Vela; Juan A Párraga-Montilla Journal: Children (Basel) Date: 2022-05-03